Partner news
News
Partner news
UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease
Read full storyPartner news
Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer
Read full storyPartner news
Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-Stage Age-Related Macular Degeneration
Read full storyPartner news
Koa Health to collaborate with Janssen: Official press release
Read full storyPartner news
BioMed X Institute starts new project in immunology research with Janssen
Read full storyPartner news
Alderley Park launches breakthrough Oncology Development Programme in collaboration with Cancer Research UK, Innovate UK, Medicines Discovery Catapult and global pharma and healthcare companies
Read full storyPartner news
BaseLaunch announces that Johnson & Johnson Innovation has renewed its commitment becoming latest strategic partner in the second phase
Read full storyPartner news
ESCAPE Bio Closes $73 Million in Crossover Financing to Advance Clinical Development of Precision Neurology Medicines for Genetic Neurodegeneration
Read full storyPartner news
Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease
Read full storyPartner news
GI Windows Raises $16.4M in Series A-1 Financing
Read full storyPartner news
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases
Read full storyPartner news
ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing
Read full storyPartner news
Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors
Read full storyPartner news